Co-Authors
This is a "connection" page, showing publications co-authored by DONALD BERRY and APOSTOLIA MARIA TSIMBERIDOU.
Connection Strength
1.051
-
Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses. Clin Cancer Res. 2014 Sep 15; 20(18):4827-36.
Score: 0.490
-
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology. NPJ Precis Oncol. 2022 Oct 27; 6(1):78.
Score: 0.218
-
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study. NPJ Precis Oncol. 2021 Mar 19; 5(1):21.
Score: 0.195
-
Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative. Clin Cancer Res. 2012 Nov 15; 18(22):6373-83.
Score: 0.108
-
A nonparametric Bayesian basket trial design. Biom J. 2019 09; 61(5):1160-1174.
Score: 0.040